Manufacturing Systems and Controls STREAM

1. OsmoTECH XT Single-Sample Micro-Osmometer Demo 8/4/2021

   This virtual presentation of the OsmoTECH XT demonstrates how easy the instrument is to use and explains its key features for osmolality measurement productivity and reliability.

2. Digitally Transforming Scientific Discovery, Research And Development 12/2/2024

   Learn how Polar, a powerful cloud-based software platform, can optimize your data management, streamline processes, and reduce time to market.

3. Building LEO Pharma's U.S. Presence with Brian Hilberdink 8/23/2023

   In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.

4. Simplifying Bioprocess Data Collection 2/17/2023

   Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.

5. A Tool To Support Your Everyday Analytical Needs 12/2/2024

   Discover the impact of a cloud-based software platform with practical applications for instrument integration, bioreactor analysis, and more.

6. Cell Insights By Umetrics® Studio 12/2/2024

   Cell Insights by Umetrics® Studio simplifies advanced data analytics for bioprocessing, offering hybrid modeling, virtual bioreactor simulations, and cell insights to streamline development, and support data-driven decisions.

7. Pragmatic Computational Biology with Andrew Satz 9/20/2023

   This week's guest on the Business of Biotech, EVQLV's Andrew Satz, says AI and ML in biopharma are like sex in high school. "Many of the people who say they're doing it really aren't, and the one who really are aren't talking about it," he says. So, when it comes to the computational biology buzz, what’s real? What’s hype? What’s yielding benefit and what’s merely vaporware?

8. Commercial Readiness with Orca Bio's Dan Kirby 9/14/2023

   Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.

9. Digital Backbone For Manufacturing And Process Quality Data 10/10/2023

   When life sciences manufacturers rely on spreadsheets and paper records, it makes creating, gathering and sharing product and process data burdensome, expensive and prone to data integrity issues.

10. CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt 10/25/2023

    What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract development and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?